{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T18:02:32Z","timestamp":1788631352680,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["7212010"],"award-info":[{"award-number":["7212010"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["7224322"],"award-info":[{"award-number":["7224322"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["7252038"],"award-info":[{"award-number":["7252038"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ijbiomac.2025.142079","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T12:35:44Z","timestamp":1742301344000},"page":"142079","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"P3","title":["Comprehensive pan-cancer analysis reveals CD70 as a promising therapeutic target and biomarker in clear cell renal cell carcinoma"],"prefix":"10.1016","volume":"307","author":[{"given":"Xuezhou","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoan","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Bo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huina","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijbiomac.2025.142079_bb0005","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.142079_bb0010","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.142079_bb0015","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.142079_bb0020","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12943-023-01876-x","article-title":"Pan-cancer spatially resolved single-cell analysis reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment","volume":"22","author":"Ma","year":"2023","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.142079_bb0025","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.cell.2024.11.010","article-title":"Pan-cancer analysis of biallelic inactivation in tumor suppressor genes identifies KEAP1 zygosity as a predictive biomarker in lung cancer","volume":"188","author":"Zucker","year":"2025","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.142079_bb0030","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1158\/0008-5472.CAN-20-2352","article-title":"Pan-cancer analysis of ligand-receptor cross-talk in the tumor microenvironment","volume":"81","author":"Ghoshdastider","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijbiomac.2025.142079_bb0035","article-title":"A mechanistic, functional, and clinical perspective on targeting CD70 in cancer","volume":"611","author":"Kumar","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ijbiomac.2025.142079_bb0040","article-title":"Molecular imaging of renal cell carcinomas: ready for prime time","author":"Wu","year":"2024","journal-title":"Nat. Rev. Urol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.142079_bb0045","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1038\/s41418-023-01217-x","article-title":"METTL3 inhibition induced by M2 macrophage-derived extracellular vesicles drives anti-PD-1 therapy resistance via M6A-CD70-mediated immune suppression in thyroid cancer","volume":"30","author":"Ning","year":"2023","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ijbiomac.2025.142079_bb0050","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.2147\/IJN.S410281","article-title":"Generation of a CD70-specific fusion nanobody with IgG recruiting capacity for tumor killing","volume":"18","author":"Liu","year":"2023","journal-title":"Int. J. Nanomedicine"},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.142079_bb0055","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/s41592-022-01606-z","article-title":"Analysis of the human protein atlas weakly supervised single-cell classification competition","volume":"19","author":"Le","year":"2022","journal-title":"Nat. Methods"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.142079_bb0060","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.142079_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1000217","article-title":"Inferring pathway activity toward precise disease classification","volume":"4","author":"Lee","year":"2008","journal-title":"PLoS Comput. Biol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.142079_bb0070","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbac558","article-title":"GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels","volume":"24","author":"Liu","year":"2023","journal-title":"Brief. Bioinform."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.142079_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The Immune Landscape of Cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"issue":"D1","key":"10.1016\/j.ijbiomac.2025.142079_bb0080","doi-asserted-by":"crossref","first-page":"D1420","DOI":"10.1093\/nar\/gkaa1020","article-title":"TISCH: a comprehensive web resource enabling interactive single-cell transcriptome visualization of tumor microenvironment","volume":"49","author":"Sun","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.142079_bb0085","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.3390\/diagnostics13111855","article-title":"Exploring the potential driver gene mutations that promote renal cancer cell metastasis and implantation based on circulating tumor cells culture","volume":"13","author":"Hong","year":"2023","journal-title":"Diagnostics (Basel)"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.142079_bb0090","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.eururo.2024.10.019","article-title":"First and second-line treatments in metastatic renal cell carcinoma","volume":"87","author":"Barragan-Carrillo","year":"2025","journal-title":"Eur. Urol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.142079_bb0095","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.euo.2024.12.011","article-title":"Treatment-free survival after first-line therapies for metastatic renal cell carcinoma: an international metastatic renal cell carcinoma database consortium analysis","volume":"8","author":"Gupta","year":"2025","journal-title":"Eur. Urol. Oncol."},{"key":"10.1016\/j.ijbiomac.2025.142079_bb0100","doi-asserted-by":"crossref","unstructured":"D. Makrakis, P. Msaouel, J.A. Karam, S.\u039c. Esagian, Cytoreductive nephrectomy in metastatic renal cell carcinoma treated with immune checkpoint inhibitors: a systematic review and meta-analysis of individual patient data, Eur. Urol. Focus S2405-4569(24) 00249-9. doi:https:\/\/doi.org\/10.1016\/j.euf.2024.11.007.","DOI":"10.1016\/j.euf.2024.11.007"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.142079_bb0105","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev-med-070623-045906","article-title":"CD70: an emerging anticancer target in renal cell carcinoma and beyond","volume":"76","author":"Zang","year":"2025","journal-title":"Annu. Rev. Med."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.142079_bb0110","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1182\/blood.2023023210","article-title":"CD70 CAR T cells secreting an anti-CD33\/anti-CD3 dual-targeting antibody overcome antigen heterogeneity in AML","volume":"145","author":"Silva","year":"2025","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.142079_bb0115","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S1470-2045(24)00508-4","article-title":"Safety and activity of CTX130, a CD70-targeted allogeneic CRISPR-Cas9-engineered CAR T-cell therapy, in patients with relapsed or refractory T-cell malignancies (COBALT-LYM): a single-arm, open-label, phase 1, dose-escalation study","volume":"26","author":"Iyer","year":"2025","journal-title":"Lancet Oncol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.142079_bb0120","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1158\/1078-0432.CCR-14-1425","article-title":"pVHL\/HIF-regulated CD70 expression is associated with infiltration of CD27+ lymphocytes and increased serum levels of soluble CD27 in clear cell renal cell carcinoma","volume":"21","author":"Ruf","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"23","key":"10.1016\/j.ijbiomac.2025.142079_bb0125","doi-asserted-by":"crossref","first-page":"8457","DOI":"10.3390\/molecules27238457","article-title":"CD70-targeted micelles enhance HIF2\u03b1 siRNA delivery and inhibit oncogenic functions in patient-derived clear cell renal carcinoma cells","volume":"27","author":"Trac","year":"2022","journal-title":"Molecules (Basel)"},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.142079_bb0130","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1080\/14712598.2024.2418321","article-title":"The future of cellular therapy for the treatment of renal cell carcinoma","volume":"24","author":"Chaoul","year":"2024","journal-title":"Expert. Opin. Biol. Ther."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.142079_bb0135","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1158\/2159-8290.CD-24-0102","article-title":"CD70-targeted allogeneic CAR T-cell therapy for advanced clear cell renal cell carcinoma","volume":"14","author":"Pal","year":"2024","journal-title":"Cancer Discov."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.142079_bb0140","article-title":"IL-21\/IL-21R signaling renders acute myeloid leukemia stem cells more susceptible to cytarabine treatment and CAR T cell therapy","volume":"5","author":"Rubino","year":"2024","journal-title":"Cell Rep. Med."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.142079_bb0145","doi-asserted-by":"crossref","first-page":"523","DOI":"10.4161\/mabs.27398","article-title":"ARGX-110, a highly potent antibody targeting CD70, eliminates tumors via both enhanced ADCC and immune checkpoint blockade","volume":"6","author":"Silence","year":"2014","journal-title":"MAbs"},{"key":"10.1016\/j.ijbiomac.2025.142079_bb0150","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev-med-062315-120245","article-title":"CAR T cell therapy for solid tumors","volume":"68","author":"Newick","year":"2017","journal-title":"Annu. Rev. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.142079_bb0155","doi-asserted-by":"crossref","first-page":"14366","DOI":"10.1038\/s41598-017-14749-3","article-title":"Micromolar affinity CAR T cells to ICAM-1 achieves rapid tumor elimination while avoiding systemic toxicity","volume":"7","author":"Park","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.142079_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2024.213855","article-title":"Ultrasound-driven facile fabrication of Pd doped SnO2 hierarchical superstructures: structural, growth mechanism, dermatoglyphics, and anti-cancer activity","volume":"160","author":"Krushna","year":"2024","journal-title":"Biomater. Adv."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.142079_bb0165","article-title":"Landscape of human organoids: ideal model in clinics and research","volume":"5","author":"Han","year":"2024","journal-title":"Innovation (Camb.)"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.142079_bb0170","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1186\/s13046-024-03258-7","article-title":"Cancer organoids as reliable disease models to drive clinical development of novel therapies","volume":"43","author":"Blandino","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025026315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025026315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T10:38:36Z","timestamp":1782902316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025026315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":34,"alternative-id":["S0141813025026315"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.142079","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive pan-cancer analysis reveals CD70 as a promising therapeutic target and biomarker in clear cell renal cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.142079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"142079"}}